JPH06329532A - Water-in-oil aerosol composition and production process thereof - Google Patents
Water-in-oil aerosol composition and production process thereofInfo
- Publication number
- JPH06329532A JPH06329532A JP5121737A JP12173793A JPH06329532A JP H06329532 A JPH06329532 A JP H06329532A JP 5121737 A JP5121737 A JP 5121737A JP 12173793 A JP12173793 A JP 12173793A JP H06329532 A JPH06329532 A JP H06329532A
- Authority
- JP
- Japan
- Prior art keywords
- water
- weight
- aerosol composition
- oil
- oil type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 98
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- 239000003921 oil Substances 0.000 claims description 106
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 235000019198 oils Nutrition 0.000 claims description 33
- 239000011550 stock solution Substances 0.000 claims description 29
- -1 fatty acid esters Chemical class 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 23
- 239000002736 nonionic surfactant Substances 0.000 claims description 23
- 239000007789 gas Substances 0.000 claims description 21
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 13
- 239000000194 fatty acid Substances 0.000 claims description 13
- 229930195729 fatty acid Natural products 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 5
- 150000002148 esters Chemical group 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical class 0.000 claims description 4
- 239000010775 animal oil Substances 0.000 claims description 3
- 239000003915 liquefied petroleum gas Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 abstract description 15
- 238000003860 storage Methods 0.000 abstract description 10
- 239000004094 surface-active agent Substances 0.000 abstract description 4
- 239000012141 concentrate Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 9
- 230000007794 irritation Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000005191 phase separation Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CNPVJWYWYZMPDS-UHFFFAOYSA-N 2-methyldecane Chemical compound CCCCCCCCC(C)C CNPVJWYWYZMPDS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- GVJHHUAWPYXKBD-QLVXXPONSA-N (S,R,R)-alpha-tocopherol Chemical compound [H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C GVJHHUAWPYXKBD-QLVXXPONSA-N 0.000 description 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- BHNZEZWIUMJCGF-UHFFFAOYSA-N 1-chloro-1,1-difluoroethane Chemical compound CC(F)(F)Cl BHNZEZWIUMJCGF-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- LRZBIPQJHILPJI-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-(2,3-dihydroxypropyl)octadecanoate Chemical compound CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCC(O)CO LRZBIPQJHILPJI-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- DUUKZBGYNMHUHO-UHFFFAOYSA-N 253MC0P0YV Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)CO DUUKZBGYNMHUHO-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- BKZCZANSHGDPSH-KTKRTIGZSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)CO BKZCZANSHGDPSH-KTKRTIGZSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 description 1
- 229960000962 bufexamac Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- QTBSBXVTEAMEQO-DYCDLGHISA-N deuterio acetate Chemical compound [2H]OC(C)=O QTBSBXVTEAMEQO-DYCDLGHISA-N 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、油中水型エアゾール組
成物およびその製法に関する。さらに詳しくは、保存安
定性および皮膚や頭髪などに対する親和性にすぐれ、さ
っぱりとした使用感を与え、たとえば化粧品、医薬部外
品、医薬品などに好適に使用しうる油中水型エアゾール
組成物、および煩雑な製造工程を必要とせず簡便に該組
成物を製造しうる方法に関する。FIELD OF THE INVENTION The present invention relates to a water-in-oil type aerosol composition and a method for producing the same. More specifically, it has excellent storage stability and affinity for skin and hair, and gives a refreshing feeling of use, for example, cosmetics, quasi-drugs, water-in-oil type aerosol compositions which can be suitably used for pharmaceuticals, And a method for easily producing the composition without requiring complicated production steps.
【0002】[0002]
【従来の技術】従来、たとえば皮膚や頭髪用のクリーム
などに用いられるエアゾール組成物としては、皮膚や頭
髪の保護などの面で油中水型エアゾール組成物がすぐれ
ていることが知られている。2. Description of the Related Art Conventionally, as an aerosol composition used for, for example, a cream for skin or hair, it is known that a water-in-oil type aerosol composition is excellent in terms of protection of skin and hair. .
【0003】しかしながら、前記油中水型エアゾール組
成物の原液を調製するには、各成分を加温し、たとえば
ホモミキサーなどで撹拌することが必要であるため、そ
の操作が非常に煩雑である。そのうえ、処方や製造条件
の設計を充分に行なったばあいであっても、大量生産時
においては、えられる油中水型エアゾール組成物の原液
にばらつきが生じ、管理が困難となったり、また使用時
のべたつきを減少させるために水分含量を増加させる
と、原液の粘度が上昇して乳化性がわるくなり、層分離
がおこりやすくなるという問題がある。However, in order to prepare the undiluted solution of the water-in-oil type aerosol composition, it is necessary to heat each component and to stir them with, for example, a homomixer, so that the operation is very complicated. . In addition, even if the formulation and manufacturing conditions are sufficiently designed, during mass production, the resulting undiluted solution of the water-in-oil type aerosol composition may vary, which makes management difficult, or When the water content is increased in order to reduce stickiness during use, there is a problem that the viscosity of the stock solution increases, the emulsifying property becomes poor, and layer separation easily occurs.
【0004】[0004]
【発明が解決しようとする課題】そこで、本発明者ら
は、前記従来技術に鑑みて鋭意研究を重ねた結果、特定
の界面活性剤が少なくともいずれか一方に配合された特
定の配合割合の油成分と水成分とを混合してえられた原
液を用いたばあいには、保存安定性および皮膚や頭髪な
どに対する親和性にすぐれ、さっぱりとした使用感を与
える油中水型エアゾール組成物が簡単にえられることを
見出し、本発明を完成するにいたった。Therefore, as a result of intensive studies conducted by the present inventors in view of the above-mentioned prior art, an oil having a specific blending ratio in which a specific surfactant is blended in at least one of them is obtained. When using a stock solution obtained by mixing a water component and a water component, a water-in-oil type aerosol composition having excellent storage stability and affinity for skin, hair, etc., and giving a refreshing feeling is obtained. They have found that they can be easily obtained, and have completed the present invention.
【0005】[0005]
【課題を解決するための手段】すなわち、本発明は、
油成分3〜50重量%、非イオン性界面活性剤0.05〜10重
量%および水成分50〜95重量%を含有してなる原液50〜
97重量%と液化ガス3〜50重量%とからなる油中水型エ
アゾール組成物、ならびに原液に対して、3〜50重量
%の油成分および0.05〜10重量%の非イオン性界面活性
剤と50〜95重量%の水成分とを混合して原液を調製し、
該原液50〜97重量%と液化ガス3〜50重量%とを混合す
ることを特徴とする油中水型エアゾール組成物の製法お
よび原液に対して、3〜50重量%の油成分と50〜95重
量%の水成分および0.05〜10重量%の非イオン性界面活
性剤とを混合して原液を調製し、該原液50〜97重量%と
液化ガス3〜50重量%とを混合することを特徴とする油
中水型エアゾール組成物の製法に関する。That is, the present invention is
An undiluted solution containing 3 to 50% by weight of an oil component, 0.05 to 10% by weight of a nonionic surfactant, and 50 to 95% by weight of a water component.
Water-in-oil type aerosol composition consisting of 97% by weight and liquefied gas 3 to 50% by weight, and 3 to 50% by weight of oil component and 0.05 to 10% by weight of nonionic surfactant relative to the stock solution. Prepare a stock solution by mixing with 50-95% by weight of water component,
50 to 97% by weight of the stock solution and 3 to 50% by weight of liquefied gas are mixed to prepare a water-in-oil type aerosol composition and the stock solution. A stock solution is prepared by mixing 95% by weight of a water component and 0.05-10% by weight of a nonionic surfactant, and 50-97% by weight of the stock solution and 3-50% by weight of a liquefied gas are mixed. The present invention relates to a method for producing a water-in-oil type aerosol composition which is characterized.
【0006】[0006]
【作用および実施例】本発明の油中水型エアゾール組成
物は、前記したように、油成分3〜50重量%、非イオン
性界面活性剤0.05〜10重量%および水成分50〜95重量%
を含有してなる原液50〜97重量%と液化ガス3〜50重量
%とからなるものである。Actions and Examples As described above, the water-in-oil type aerosol composition of the present invention comprises 3 to 50% by weight of an oil component, 0.05 to 10% by weight of a nonionic surfactant and 50 to 95% by weight of a water component.
It is composed of 50 to 97% by weight of a stock solution containing 3 to 50% by weight of liquefied gas.
【0007】前記原液に用いられる油成分は、皮膚や毛
髪に対する浸透性や光沢を付与したり、保護してその健
康な状態を維持し、伸展性を良好にするための成分であ
り、かかる目的のために用いることができるものであれ
ばとくに限定がないが、常温で液状を呈し、人体用のも
のであるという点から炭化水素類、植物油、動物油およ
び脂肪酸エステルから選ばれた少なくとも1種であるこ
とが好ましい。The oil component used in the undiluted solution is a component for imparting penetrability and luster to skin and hair, protecting it to maintain its healthy state and improving extensibility. It is not particularly limited as long as it can be used for, but it is at least one selected from hydrocarbons, vegetable oils, animal oils and fatty acid esters because it is liquid at room temperature and is intended for the human body. Preferably there is.
【0008】前記油成分の具体例としては、たとえば流
動パラフィン、たとえばアイソパーA、アイソパーC、
アイソパーD、アイソパーE、アイソパーG、アイソパ
ーH、アイソパーK、アイソパーL、アイソパーM(以
上、エクソン社製)などのイソパラフィン系炭化水素、
ワセリン、スクワラン、α−オレフィンオリゴマー、ス
クワレンなどの炭化水素類;オリーブ油、アーモンド
油、ホホバ油、落花生油、ヒマシ油、ヤシ油、パーム
油、サフラワー油、ヒマワリ油、綿実油、アボカド油、
ツバキ油、トウモロコシ油、小麦胚芽油、コメヌカ油、
カカオ脂、ゴマ油、月見草油、紅花油、サザンカ油、大
豆油、ナタネ油などの植物油;ラノリン、ラノリン誘導
体、タートル油、ミンク油、ミツロウ、プリスタン、卵
黄油などの動物油;ブチルステアレート、ヘキシルラウ
レート、イソプロピルミリステート、オクチルドデシル
ミリステート、イソプロピルパルミテート、ジイソプロ
ピルアジペート、ジイソプロピルセバケートなどの脂肪
酸エステルなどがあげられ、これらは単独でまたは2種
以上を混合して用いることができる。Specific examples of the oil component include, for example, liquid paraffin such as Isopar A, Isopar C,
Isoparaffinic hydrocarbons such as Isopar D, Isopar E, Isopar G, Isopar H, Isopar K, Isopar L, Isopar M (above, exon),
Hydrocarbons such as petrolatum, squalane, α-olefin oligomer, squalene; olive oil, almond oil, jojoba oil, peanut oil, castor oil, coconut oil, palm oil, safflower oil, sunflower oil, cottonseed oil, avocado oil,
Camellia oil, corn oil, wheat germ oil, rice bran oil,
Cocoa butter, sesame oil, evening primrose oil, safflower oil, southern oil, soybean oil, rapeseed oil and other vegetable oils; lanolin, lanolin derivatives, turtle oil, mink oil, beeswax, pristane, egg yolk oil and other animal oils; butyl stearate, hexyl laurel Examples thereof include fatty acid esters such as rate, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, diisopropyl adipate, and diisopropyl sebacate, and these can be used alone or in admixture of two or more.
【0009】原液に対する油成分の配合割合は、3〜50
重量%、好ましくは5〜40重量%である。かかる油成分
の配合割合が3重量%未満であるばあいには、えられる
油中水型エアゾール組成物の伸びがわるくなるようにな
り、また50重量%をこえるばあいには、油中水型エアゾ
ール組成物にべたつきが生じるようになる。The mixing ratio of the oil component to the stock solution is 3 to 50.
%, Preferably 5-40% by weight. When the blending ratio of such an oil component is less than 3% by weight, the water-in-oil type aerosol composition to be obtained becomes poor in elongation, and when it exceeds 50% by weight, the water-in-oil composition is increased. The type aerosol composition becomes sticky.
【0010】前記原液に用いられる非イオン性界面活性
剤は、油中水型エアゾール組成物をうるための乳化剤と
して作用する成分である。The nonionic surfactant used in the undiluted solution is a component which acts as an emulsifier for obtaining a water-in-oil type aerosol composition.
【0011】前記非イオン性界面活性剤の具体例として
は、たとえばポリグリセリン脂肪酸エステル、デカグリ
セリン脂肪酸エステル、ジグリセリン脂肪酸エステル、
モノグリセリン脂肪酸エステル、ソルビタン脂肪酸エス
テル、ポリオキシエチレンソルビタン脂肪酸エステル、
ポリオキシエチレンソルビット脂肪酸エステル、ポリオ
キシエチレンラノリン、ポリエチレングリコール脂肪酸
エステル、ショ糖脂肪酸エステルなどのエステル型非イ
オン性界面活性剤、ポリオキシエチレンアルキルエーテ
ル、ポリオキシエチレンポリオキシプロピレンアルキル
エーテル、ポリオキシエチレンアルキルフェニルエーテ
ルなどのエーテル型非イオン性界面活性剤、ポリオキシ
エチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油な
どのエーテルエステル型非イオン性界面活性剤などがあ
げられ、これらは単独でまたは2種以上を混合して用い
ることができるが、これらのなかでは、えられる油中水
型エアゾール組成物のべたつきを減少させるために後述
する水成分の配合割合を多くしたばあいであっても、乳
化力が低下しにくいという点からエステル型非イオン性
界面活性剤が好ましく、とくにポリグリセリン脂肪酸エ
ステルが好ましい。Specific examples of the nonionic surfactant include polyglycerin fatty acid ester, decaglycerin fatty acid ester, diglycerin fatty acid ester, and the like.
Monoglycerin fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester,
Ester type nonionic surfactants such as polyoxyethylene sorbit fatty acid ester, polyoxyethylene lanolin, polyethylene glycol fatty acid ester, sucrose fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene Examples include ether type nonionic surfactants such as alkyl phenyl ether, and ether ester type nonionic surfactants such as polyoxyethylene castor oil and polyoxyethylene hydrogenated castor oil. These may be used alone or in combination of two or more. Among these, the emulsifying power can be increased even if the mixing ratio of the water component described below is increased in order to reduce the stickiness of the obtained water-in-oil type aerosol composition. Is hard to fall Preferably ester type nonionic surface active agents in terms of, in particular the polyglycerol fatty acid ester is preferable.
【0012】原液に対する非イオン性界面活性剤の配合
割合は、0.05〜10重量%、好ましくは0.1 〜7重量%で
ある。かかる非イオン性界面活性剤の配合割合が0.05重
量%未満であるばあいには、乳化力が不充分となって相
分離が生じ、目的とする油中水型エアゾール組成物がえ
られなくなるようになり、また10重量%をこえるばあい
には、界面活性剤そのもののべたつきが大きくなり、油
中水型エアゾール組成物にべたつきが生じるようにな
る。The blending ratio of the nonionic surfactant to the stock solution is 0.05 to 10% by weight, preferably 0.1 to 7% by weight. When the blending ratio of the nonionic surfactant is less than 0.05% by weight, the emulsifying power becomes insufficient and phase separation occurs, so that the desired water-in-oil type aerosol composition cannot be obtained. When it exceeds 10% by weight, the surfactant itself becomes too sticky, and the water-in-oil type aerosol composition becomes sticky.
【0013】前記原液に用いられる水成分は、えられる
油中水型エアゾール組成物がさっぱりとした使用感を呈
するようにするための成分であり、かかる水成分にはと
くに限定がなく、通常エアゾール組成物に用いられる蒸
留水、イオン交換水などの精製水などを用いることがで
きる。The water component used in the undiluted solution is a component for making the obtained water-in-oil type aerosol composition have a refreshing feeling of use, and the water component is not particularly limited, and is usually an aerosol. Purified water such as distilled water or ion-exchanged water used for the composition can be used.
【0014】原液に対する水成分の配合割合は、50〜95
重量%、好ましくは40〜90重量%である。かかる水成分
の配合割合が50重量%未満であるばあいには、えられる
油中水型エアゾール組成物のさっぱりとした使用感が低
下するようになり、また95重量%をこえるばあいには、
前記油成分、非イオン性界面活性剤などのそのほかの成
分の配合量が少なくなり、目的とする油中水型エアゾー
ル組成物がえられなくなるようになる。The mixing ratio of the water component to the stock solution is 50 to 95.
%, Preferably 40-90% by weight. When the blending ratio of the water component is less than 50% by weight, the refreshing feeling of the obtained water-in-oil type aerosol composition is deteriorated, and when it exceeds 95% by weight. ,
The blending amount of the other components such as the oil component and the nonionic surfactant becomes small, and the desired water-in-oil type aerosol composition cannot be obtained.
【0015】本発明に用いられる原液は、それぞれの所
望量が前記範囲内で調整された油成分、非イオン性界面
活性剤および水成分を混合することによって調製され
る。The stock solution used in the present invention is prepared by mixing an oil component, a nonionic surfactant, and a water component, each of which is adjusted to have a desired amount within the above range.
【0016】なお、本発明においては、かかる原液の調
製の際に、非イオン性界面活性剤を油成分または水成分
のいずれか一方のみに配合したのちに、かかる油成分と
水成分とを混合してもよく、油成分および水成分の両成
分に配合したのちに、かかる油成分と水成分とを混合し
てもよい。In the present invention, in the preparation of such a stock solution, the nonionic surfactant is blended with either the oil component or the water component, and then the oil component and the water component are mixed. Alternatively, the oil component and the water component may be mixed after being mixed with both the oil component and the water component.
【0017】本発明に用いられる原液は、前記したよう
に、油成分、非イオン性界面活性剤および水成分を含有
したものであるが、これらのほかにも、たとえばインド
メタシン、ブフェキサマック、ケトプロフェン、デキサ
メタゾン、イオウ、トルナフテート、シリカマイクロビ
ーズ、たとえば酸化亜鉛などにシリコーン処理を施した
パウダーなどの親油性粉末;エタノール、イソプロパノ
ールなどの1価アルコール、エチレングリコール、ジエ
チレングリコール、トリエチレングリコール、プロピレ
ングリコール、グリセリン、1,3−ブチレングリコー
ルなどの多価アルコールなどのアルコール類;酢酸−d
l−α−トコフェロール、アズレン、l−メントール、
dl−カンフルなどの薬理活性物質;有効成分;香料;
メチルパラベンなどのパラ安息香酸エステルなどの防腐
剤;ジブチルヒドロキシトルエンなどの酸化防止剤;パ
ラジメチルアミノ安息香酸オクチル、メトキシケイ皮酸
オクチルなどの紫外線吸収剤などのたとえば化粧品、医
薬部外品、医薬品などに通常用いられる成分を、用途に
応じて本発明の目的が阻害されない範囲内で適宜選択し
て配合することができる。これらの成分は、原液を調製
する際に、前記油成分または水成分のいずれか一方のみ
に配合してもよく、両成分に配合してもよく、とくに限
定はない。As described above, the stock solution used in the present invention contains an oil component, a nonionic surfactant and a water component. In addition to these, for example, indomethacin, bufexamac, ketoprofen. , Dexamethasone, sulfur, tolnaftate, silica microbeads, lipophilic powders such as powders obtained by subjecting zinc oxide to a silicone treatment; monohydric alcohols such as ethanol and isopropanol, ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, glycerin , Alcohols such as polyhydric alcohols such as 1,3-butylene glycol; acetic acid-d
l-α-tocopherol, azulene, l-menthol,
pharmacologically active substances such as dl-camphor; active ingredients; fragrances;
Antiseptics such as parabenzoic acid esters such as methylparaben; Antioxidants such as dibutylhydroxytoluene; UV absorbers such as octyl paradimethylaminobenzoate and octyl methoxycinnamate, for example, cosmetics, quasi drugs, pharmaceuticals, etc. The components usually used in the above can be appropriately selected and blended depending on the application within a range not impairing the object of the present invention. These components may be blended with only one of the oil component and the water component when preparing a stock solution, or may be blended with both components, and there is no particular limitation.
【0018】なお、本発明においては、分散性がさらに
向上し、凝集がきわめて生じにくい油中水型エアゾール
組成物がえられるという点から、前記親油性粉末を、原
液に対して30重量%以下、なかんづく1〜15重量%の範
囲内で配合することが好ましい。かかる親油性粉末の配
合割合が30重量%をこえるばあいには、えられる油中水
型エアゾール組成物を用いてエアゾール製品としたとき
に、バルブなどで目詰まりをおこす可能性が生じる傾向
がある。In the present invention, from the viewpoint that the dispersibility is further improved and a water-in-oil type aerosol composition in which agglomeration hardly occurs, the lipophilic powder is contained in an amount of 30% by weight or less based on the stock solution. Especially, it is preferable to mix within the range of 1 to 15% by weight. When the blending ratio of the lipophilic powder is more than 30% by weight, when the obtained water-in-oil type aerosol composition is used as an aerosol product, there is a tendency that clogging may occur in a valve or the like. is there.
【0019】本発明に噴射剤として用いられる液化ガス
としては、たとえばプロパン、i−ブタンおよびn−ブ
タンを主成分とする液化石油ガス、ジメチルエーテル、
ジフルオロモノクロロエタン、モノクロロジフルオロメ
タン、テトラフルオロエタンなどのハイドロフルオロカ
ーボンなどがあげられ、これらは単独でまたは2種以上
を混合して用いることができるが、これらのなかでは乳
化性にすぐれ、目的とする油中水型エアゾール組成物を
容易にうることができるという点から液化石油ガスが好
ましい。Examples of the liquefied gas used as the propellant in the present invention include liquefied petroleum gas containing propane, i-butane and n-butane as main components, dimethyl ether,
Examples thereof include hydrofluorocarbons such as difluoromonochloroethane, monochlorodifluoromethane, and tetrafluoroethane. These can be used alone or in admixture of two or more. Among them, the emulsifying property is excellent and the objective is Liquefied petroleum gas is preferable from the viewpoint that a water-in-oil type aerosol composition can be easily obtained.
【0020】前記原液と液化ガスとを混合し、軽く振盪
することによって本発明の油中水型エアゾール組成物が
えられる。The water-in-oil type aerosol composition of the present invention can be obtained by mixing the above-mentioned stock solution and the liquefied gas and gently shaking.
【0021】前記原液と液化ガスとの配合割合は、原液
50〜97重量%、好ましくは60〜95重量%、すなわち液化
ガス3〜50重量%、好ましくは5〜40重量%である。か
かる原液の配合割合が50重量%未満、すなわち液化ガス
の配合割合が50重量%をこえるばあいには、えられる油
中水型エアゾール組成物を噴射させたときに飛散がいち
じるしくなったり、被噴射物への組成物の付着量が少な
くなるようになり、また原液の配合割合が97重量%をこ
える、すなわち液化ガスの配合割合が3重量%未満であ
るばあいには、噴射力が小さく、エアゾール組成物とし
ての機能を果たしにくくなる。The mixing ratio of the stock solution and the liquefied gas is as follows.
50 to 97% by weight, preferably 60 to 95% by weight, ie 3 to 50% by weight of liquefied gas, preferably 5 to 40% by weight. If the blending ratio of such a stock solution is less than 50% by weight, that is, if the blending ratio of the liquefied gas exceeds 50% by weight, the resulting water-in-oil type aerosol composition may be easily scattered, The amount of the composition deposited on the propellant will decrease, and if the mixture ratio of the undiluted liquid exceeds 97% by weight, that is, if the mixture ratio of liquefied gas is less than 3% by weight, the injection force will be small. , It becomes difficult to perform the function as an aerosol composition.
【0022】かくしてえられる油中水型エアゾール組成
物を通常の方法でエアゾール用耐圧容器内に充填し、エ
アゾール用バルブを取り付けることによってエアゾール
製品とすることができる。The water-in-oil type aerosol composition thus obtained is filled in a pressure resistant container for an aerosol by a usual method, and an aerosol valve can be attached to obtain an aerosol product.
【0023】前記エアゾール用耐圧容器にはとくに限定
がなく、通常用いられる容器を適用することができる。
また、該エアゾール用耐圧容器内に油中水型エアゾール
組成物を充填する際には、通常製品の内圧が35℃で8k
g/cm2 ・G以下、なかんづく7kg/cm2 ・G以
下となるように調整することが、安全性の面から好まし
い。The pressure resistant container for aerosol is not particularly limited, and a commonly used container can be applied.
When the water-in-oil type aerosol composition is filled in the pressure container for aerosol, the internal pressure of the product is usually 8 k at 35 ° C.
From the viewpoint of safety, it is preferable to adjust to g / cm 2 · G or less, especially 7 kg / cm 2 · G or less.
【0024】なお、本発明においては、前記したよう
に、油成分または水成分のいずれか一方もしくは両成分
に非イオン性界面活性剤を配合し、該油成分および水成
分を混合してえられた原液と、液化ガスとを混合するこ
とによって油中水型エアゾール組成物を製造し、該組成
物をエアゾール用耐圧容器内に充填することができる
が、エアゾール用耐圧容器内に油成分と水成分とを別々
に充填して原液としたのち、該エアゾール用耐圧容器内
に液化ガスを充填し、内容物を振盪して混合することに
より、エアゾール用耐圧容器内において油中水型エアゾ
ール組成物を製造することもできる。In the present invention, as described above, a nonionic surfactant is added to either or both of the oil component and the water component, and the oil component and the water component are mixed. It is possible to produce a water-in-oil type aerosol composition by mixing the stock solution and the liquefied gas, and to fill the composition in the aerosol pressure-resistant container. After separately filling the components with each other to prepare a stock solution, the aerosol pressure-resistant container is filled with a liquefied gas, and the contents are shaken to mix to give a water-in-oil aerosol composition in the aerosol pressure-resistant container. Can also be manufactured.
【0025】前記油中水型エアゾール組成物の噴射形態
にはとくに限定がなく、たとえば霧状、フォーム状、ス
トリーム状、液滴状、ペースト状などがあげられる。The form of injection of the water-in-oil type aerosol composition is not particularly limited, and examples thereof include mist form, foam form, stream form, droplet form, paste form and the like.
【0026】本発明の製法は、煩雑な工程を必要とせ
ず、簡便にエアゾール組成物を製造しうる方法であり、
該製法によってえられるエアゾール組成物は、油中水型
のものであり、相分離がおこらず保存安定性にすぐれ、
また皮膚や頭髪などに対する刺激が少なく親和性にすぐ
れ、さらにべたつきがなくさっぱりとした使用感を与え
ることから、たとえば化粧品、医薬部外品、医薬品など
に好適に使用することができる。The production method of the present invention is a method which can easily produce an aerosol composition without requiring complicated steps,
The aerosol composition obtained by the production method is of a water-in-oil type and has excellent storage stability without phase separation.
Further, since it is less irritating to the skin and hair, has excellent affinity, and gives a refreshing feeling without stickiness, it can be suitably used for cosmetics, quasi-drugs, pharmaceuticals and the like.
【0027】つぎに、本発明の油中水型エアゾール組成
物およびその製法を実施例に基づいてさらに詳細に説明
するが、本発明はかかる実施例のみに限定されるもので
はない。Next, the water-in-oil type aerosol composition of the present invention and the method for producing the same will be described in more detail based on examples, but the present invention is not limited to these examples.
【0028】実施例1 表1に示す油成分(A)および水成分(B)をエアゾー
ル用耐圧容器(満注量:160 ml)内に別々に充填して
混合したのち、噴射剤として表1に示す液化ガス(C)
を充填し、エアゾール用バルブを取り付け、軽く振盪し
ながら混合し、ソフトポマードとしての油中水型エアゾ
ール組成物が充填されたエアゾール製品をえた。Example 1 The oil component (A) and the water component (B) shown in Table 1 were separately filled in a pressure container for aerosol (full injection amount: 160 ml) and mixed, and then used as a propellant in Table 1. Gas (C) shown in
Was added, an aerosol valve was attached, and the mixture was mixed with light shaking to obtain an aerosol product filled with the water-in-oil type aerosol composition as a soft pomade.
【0029】なお、このときの内圧は、35℃で4kg/
cm2 ・Gとなるように調整した。The internal pressure at this time is 4 kg / 35 ° C.
It was adjusted to be cm 2 · G.
【0030】[0030]
【表1】 [Table 1]
【0031】えられた油中水型エアゾール組成物の保存
安定性を、調製直後に噴射した組成物の状態と室温で1
カ月間放置したのちに噴射した組成物の状態とをそれぞ
れ目視にて観察して調べ、以下の評価基準に基づいて評
価した。その結果を表6に示す。The storage stability of the obtained water-in-oil type aerosol composition was measured at room temperature and the state of the composition sprayed immediately after preparation.
The state of the composition sprayed after being left for a month was visually inspected and examined, and evaluated based on the following evaluation criteria. The results are shown in Table 6.
【0032】(評価基準) A:1カ月間放置後も均一に噴射することができ、噴射
した油中水型エアゾール組成物の状態にまったく変化が
ない。 B:1カ月間放置後、噴射した油中水型エアゾール組成
物中で相分離がおこる。 C:1カ月間放置後、噴射した油中水型エアゾール組成
物が完全に相分離している。(Evaluation Criteria) A: Even after left standing for 1 month, uniform injection is possible, and there is no change in the state of the injected water-in-oil type aerosol composition. B: Phase separation occurs in the sprayed water-in-oil type aerosol composition after standing for 1 month. C: After being left for 1 month, the sprayed water-in-oil type aerosol composition was completely phase-separated.
【0033】つぎに、油中水型エアゾール組成物3gを
頭髪に噴射して整髪し、その整髪効果を調べたところ、
該油中水型エアゾール組成物を噴射した部分は、噴射し
なかった部分と比べてきれいに整髪することができ、該
油中水型エアゾール組成物が整髪効果を呈することがわ
かった。Next, 3 g of the water-in-oil type aerosol composition was sprayed onto the hair for hair styling, and the hair styling effect was examined.
It was found that the portion where the water-in-oil type aerosol composition was sprayed had a better hair styling than the portion where it was not sprayed, and the water-in-oil type aerosol composition exhibited a hair styling effect.
【0034】また、えられた油中水型エアゾール組成物
の特性として、頭髪に対するなじみ、べたつき感および
皮膚に対する刺激について、無作為に抽出した男性50名
のパネラーの頭部(頭髪)に油中水型エアゾール組成物
3gを噴射して調べ、各々以下の評価基準に基づいて評
価した。その結果を表6に示す。As characteristics of the obtained water-in-oil type aerosol composition, about the familiarity to the hair, the feeling of stickiness and the irritation to the skin, the heads (heads) of 50 randomly selected males were immersed in the oil. 3 g of the water-based aerosol composition was jetted and examined, and each was evaluated based on the following evaluation criteria. The results are shown in Table 6.
【0035】(評価基準) (イ)頭髪に対するなじみ A:40名以上がなじみがよいと感じた。 B:30〜39名がなじみがよいと感じた。 C:20〜29名がなじみがよいと感じた。 D:10〜19名がなじみがよいと感じた。 E:9名以下しかなじみがよいと感じなかった。(Evaluation Criteria) (a) Familiarity with Hair A: 40 or more people felt that they were familiar. B: 30 to 39 people felt familiar. C: 20 to 29 people felt familiar. D: 10 to 19 people felt familiar. E: Only 9 people or less felt familiar.
【0036】(ロ)べたつき感 A:9名以下がべたつき感があると感じた。 B:10〜19名がべたつき感があると感じた。 C:20〜29名がべたつき感があると感じた。 D:30〜39名がべたつき感があると感じた。 E:40名以上がべたつき感があると感じた。(B) Sticky feeling A: 9 or less people felt that there was sticky feeling. B: 10 to 19 people felt that it was sticky. C: 20 to 29 people felt that it was sticky. D: 30 to 39 people felt that it was sticky. E: More than 40 people felt sticky.
【0037】(ハ)皮膚に対する刺激 A:9名以下が皮膚に刺激を感じた。 B:10〜19名が皮膚に刺激を感じた。 C:20〜29名が皮膚に刺激を感じた。 D:30〜39名が皮膚に刺激を感じた。 E:40名以上が皮膚に刺激を感じた。(C) Skin irritation A: 9 or less people felt irritation on the skin. B: 10 to 19 people felt irritation on the skin. C: 20 to 29 people felt irritation on the skin. D: 30 to 39 people felt irritation on the skin. E: More than 40 people felt irritation on the skin.
【0038】実施例2 実施例1において、用いた油成分(A)、水成分(B)
および液化ガス(C)を表2に示すように変更したほか
は実施例1と同様にして紫外線カットクリームとしての
油中水型エアゾール組成物が充填されたエアゾール製品
をえた。Example 2 Oil component (A) and water component (B) used in Example 1
Further, an aerosol product filled with the water-in-oil type aerosol composition as an ultraviolet cut cream was obtained in the same manner as in Example 1 except that the liquefied gas (C) was changed as shown in Table 2.
【0039】[0039]
【表2】 [Table 2]
【0040】えられた油中水型エアゾール組成物の保存
安定性を実施例1と同様にして調べた。その結果を表6
に示す。The storage stability of the obtained water-in-oil type aerosol composition was examined in the same manner as in Example 1. The results are shown in Table 6
Shown in.
【0041】つぎに、油中水型エアゾール組成物2gを
片頬に噴射し、晴天下3時間屋外で過ごしたのち、その
紫外線遮断効果を調べたところ、該油中水型エアゾール
組成物を噴射しなかった頬は赤くなっているのに対し、
噴射した頬はまったく変化がなく、該油中水型エアゾー
ル組成物が紫外線遮断効果を呈することがわかった。Next, 2 g of the water-in-oil type aerosol composition was sprayed on one cheek, and after spending 3 hours outdoors in fine weather, the effect of blocking the ultraviolet rays was examined. The water-in-oil type aerosol composition was sprayed. The cheeks I didn't do became red,
It was found that the sprayed cheek did not change at all, and the water-in-oil type aerosol composition exhibited a UV blocking effect.
【0042】また、油中水型エアゾール組成物の特性と
して、皮膚に対するなじみ、べたつき感および皮膚に対
する刺激について、無作為に抽出した女性50名のパネラ
ーの頬に油中水型エアゾール組成物2gを噴射して調
べ、各々実施例1で用いた評価基準と同様(ただし、皮
膚に対するなじみについては、実施例1における(イ)
頭髪に対するなじみの評価基準と同様)の評価基準に基
づいて評価した。その結果を表6に示す。Regarding the characteristics of the water-in-oil type aerosol composition, 2 g of the water-in-oil type aerosol composition was applied to the cheeks of 50 randomly selected panelists regarding the familiarity to the skin, the feeling of stickiness and the irritation to the skin. It is sprayed and examined, and each is the same as the evaluation criteria used in Example 1 (however, regarding familiarity with the skin, (a) in Example 1)
Evaluation was made based on the same evaluation standard as that for familiarity with hair). The results are shown in Table 6.
【0043】実施例3 実施例1において、用いた油成分(A)、水成分(B)
および液化ガス(C)を表3に示すように変更したほか
は実施例1と同様にして皮膚疾患剤(消炎剤)としての
油中水型エアゾール組成物が充填されたエアゾール製品
をえた。Example 3 Oil component (A) and water component (B) used in Example 1
Further, an aerosol product filled with the water-in-oil type aerosol composition as a skin disease agent (anti-inflammatory agent) was obtained in the same manner as in Example 1 except that the liquefied gas (C) was changed as shown in Table 3.
【0044】[0044]
【表3】 [Table 3]
【0045】えられた油中水型エアゾール組成物の保存
安定性を実施例1と同様にして調べた。その結果を表6
に示す。The storage stability of the obtained water-in-oil type aerosol composition was examined in the same manner as in Example 1. The results are shown in Table 6
Shown in.
【0046】つぎに、油中水型エアゾール組成物3gを
上腕部の炎症部分に噴射してその消炎効果を調べたとこ
ろ、炎症がほぼおさまり、該油中水型エアゾール組成物
が消炎効果を呈することがわかった。Next, 3 g of the water-in-oil type aerosol composition was sprayed onto the inflamed part of the upper arm to examine its anti-inflammatory effect. When the inflammation was subsided, the water-in-oil type aerosol composition exhibited an anti-inflammatory effect. I understood it.
【0047】また、油中水型エアゾール組成物の特性を
実施例2と同様にして調べ(ただし、無作為に抽出した
男女50名のパネラーの上腕部に噴射)、評価した。その
結果を表6に示す。Further, the properties of the water-in-oil type aerosol composition were examined in the same manner as in Example 2 (however, sprayed on the upper arms of 50 randomly selected male and female panelists) and evaluated. The results are shown in Table 6.
【0048】実施例4 実施例1において、用いた油成分(A)、水成分(B)
および液化ガス(C)を表4に示すように変更したほか
は実施例1と同様にしてナイトクリームとしての油中水
型エアゾール組成物が充填されたエアゾール製品をえ
た。Example 4 Oil component (A) and water component (B) used in Example 1
Also, an aerosol product filled with the water-in-oil type aerosol composition as a night cream was obtained in the same manner as in Example 1 except that the liquefied gas (C) was changed as shown in Table 4.
【0049】[0049]
【表4】 [Table 4]
【0050】えられた油中水型エアゾール組成物の保存
安定性を実施例1と同様にして調べた。その結果を表6
に示す。The storage stability of the obtained water-in-oil type aerosol composition was examined in the same manner as in Example 1. The results are shown in Table 6
Shown in.
【0051】つぎに、油中水型エアゾール組成物2gを
片頬に噴射して一晩就寝したのち、その保湿(うるおい
付与)効果を調べたところ、該油中水型エアゾール組成
物を噴射した頬は、噴射しなかった頬と比べてしっとり
としてうるおいがあり、該油中水型エアゾール組成物が
保湿(うるおい付与)効果を呈することがわかった。Next, 2 g of the water-in-oil type aerosol composition was sprayed on one cheek and after going to bed overnight, its moisturizing (moisture-imparting) effect was examined. The water-in-oil type aerosol composition was sprayed. The cheeks were moist and moisturized as compared to the non-sprayed cheeks, and it was found that the water-in-oil type aerosol composition exhibits a moisturizing effect (moisturizing effect).
【0052】また、油中水型エアゾール組成物の特性を
実施例2と同様にして調べ、評価した。その結果を表6
に示す。The characteristics of the water-in-oil type aerosol composition were examined and evaluated in the same manner as in Example 2. The results are shown in Table 6
Shown in.
【0053】実施例5 実施例1において、用いた油成分(A)、水成分(B)
および液化ガス(C)を表5に示すように変更したほか
は実施例1と同様にして水虫薬としての油中水型エアゾ
ール組成物が充填されたエアゾール製品をえた。Example 5 Oil component (A) and water component (B) used in Example 1
Also, an aerosol product filled with the water-in-oil type aerosol composition as an athlete's foot drug was obtained in the same manner as in Example 1 except that the liquefied gas (C) was changed as shown in Table 5.
【0054】[0054]
【表5】 [Table 5]
【0055】えられた油中水型エアゾール組成物の保存
安定性を実施例1と同様にして調べた。その結果を表6
に示す。The storage stability of the obtained water-in-oil type aerosol composition was examined in the same manner as in Example 1. The results are shown in Table 6
Shown in.
【0056】つぎに、油中水型エアゾール組成物1gを
足指の水虫部分に2週間にわたって噴射してその治癒効
果を調べたところ、水虫がほぼ治癒され、該油中水型エ
アゾール組成物が水虫の治癒効果を呈するものであるこ
とがわかった。Next, 1 g of the water-in-oil type aerosol composition was sprayed onto the athlete's foot part for 2 weeks to examine the healing effect. As a result, athlete's foot was almost healed and the water-in-oil type aerosol composition It was found to exhibit a healing effect on athlete's foot.
【0057】また、油中水型エアゾール組成物の特性を
実施例2と同様にして調べ(ただし、無作為に抽出した
男性50名のパネラーの足指に噴射)、評価した。その結
果を表6に示す。Further, the properties of the water-in-oil type aerosol composition were examined in the same manner as in Example 2 (however, sprayed on the toes of 50 randomly selected male panelists) and evaluated. The results are shown in Table 6.
【0058】なお、表1〜5に示す各成分は、以下に示
すとおりである。The components shown in Tables 1 to 5 are as shown below.
【0059】流動パラフィン ハイコールK−140 、金田(株)製 ジグリセリルモノオレエート NIKKOL DGMO−C、日光ケミカルズ(株)製 デカグリセリルペンタオレエート NIKKOL Decaglyn 5−0、日光ケミカ
ルズ(株)製 ジグリセリルジオレエート NIKKOL DGMO、日光ケミカルズ(株)製 ジグリセリルモノステアレート NIKKOL DGMS、日光ケミカルズ(株)製Liquid paraffin Hicol K-140, diglyceryl monooleate NIKKOL DGMO-C manufactured by Kaneda, decaglyceryl pentaoleate NIKKOL Decaglyn 5-0 manufactured by Nikko Chemicals, diglyceryl manufactured by Nikko Chemicals Dioleate NIKKOL DGMO, manufactured by Nikko Chemicals Co., Ltd. Diglyceryl monostearate NIKKOL DGMS, manufactured by Nikko Chemicals Co., Ltd.
【0060】[0060]
【表6】 [Table 6]
【0061】表6に示された結果から、実施例1〜5で
えられた油中水型エアゾール組成物は、長期間保存した
ばあいであっても相分離がおこらず、なじみがよく、べ
たつき感および皮膚に対する刺激がないすぐれたもので
あることがわかる。From the results shown in Table 6, the water-in-oil type aerosol compositions obtained in Examples 1 to 5 did not cause phase separation even when stored for a long period of time and had good compatibility. It can be seen that the product is excellent without stickiness and irritation to the skin.
【0062】[0062]
【発明の効果】本発明の製法は、煩雑な工程を必要とせ
ず簡便にエアゾール組成物を製造しうる方法であり、該
製法によってえられる油中水型エアゾール組成物は、相
分離がおこらず保存安定性にすぐれ、また皮膚や頭髪な
どに対する刺激が少なく親和性にすぐれ、さらにべたつ
きがなくさっぱりとした使用感を与えることから、たと
えば化粧品、医薬部外品、医薬品などに好適に使用する
ことができる。The production method of the present invention is a method capable of easily producing an aerosol composition without requiring complicated steps, and the water-in-oil type aerosol composition obtained by the production method does not undergo phase separation. It has excellent storage stability, less irritation to the skin and hair, excellent affinity, and gives a refreshing feeling without stickiness, so it is suitable for use in cosmetics, quasi-drugs, pharmaceuticals, etc. You can
Claims (8)
性剤0.05〜10重量%および水成分50〜95重量%を含有し
てなる原液50〜97重量%と液化ガス3〜50重量%とから
なる油中水型エアゾール組成物。1. 50 to 97% by weight of a stock solution containing 3 to 50% by weight of an oil component, 0.05 to 10% by weight of a nonionic surfactant and 50 to 95% by weight of a water component, and 3 to 50% by weight of a liquefied gas. % Water-in-oil type aerosol composition.
よび脂肪酸エステルから選ばれた少なくとも1種である
請求項1記載の油中水型エアゾール組成物。2. The water-in-oil type aerosol composition according to claim 1, wherein the oil component is at least one selected from hydrocarbons, vegetable oils, animal oils and fatty acid esters.
オン性界面活性剤である請求項1または2記載の油中水
型エアゾール組成物。3. The water-in-oil type aerosol composition according to claim 1, wherein the nonionic surfactant is an ester type nonionic surfactant.
1、2または3記載の油中水型エアゾール組成物。4. The water-in-oil type aerosol composition according to claim 1, 2 or 3, wherein the liquefied gas is liquefied petroleum gas.
請求項1、2、3または4記載の油中水型エアゾール組
成物。5. The water-in-oil type aerosol composition according to claim 1, 2, 3 or 4, wherein the undiluted solution contains a lipophilic powder.
よび0.05〜10重量%の非イオン性界面活性剤と50〜95重
量%の水成分とを混合して原液を調製し、該原液50〜97
重量%と液化ガス3〜50重量%とを混合することを特徴
とする油中水型エアゾール組成物の製法。6. A stock solution is prepared by mixing 3 to 50% by weight of an oil component, 0.05 to 10% by weight of a nonionic surfactant and 50 to 95% by weight of a water component with respect to the stock solution, The stock solution 50-97
A method for producing a water-in-oil type aerosol composition, characterized by mixing 3% by weight and 3 to 50% by weight of a liquefied gas.
50〜95重量%の水成分および0.05〜10重量%の非イオン
性界面活性剤とを混合して原液を調製し、該原液50〜97
重量%と液化ガス3〜50重量%とを混合することを特徴
とする油中水型エアゾール組成物の製法。7. An oil component of 3 to 50% by weight based on the stock solution.
A stock solution was prepared by mixing 50 to 95% by weight of a water component and 0.05 to 10% by weight of a nonionic surfactant.
A method for producing a water-in-oil type aerosol composition, characterized by mixing 3% by weight and 3 to 50% by weight of a liquefied gas.
の量との合計が原液に対して0.05〜10重量%となるよう
に、油成分に非イオン性界面活性剤を配合する請求項7
記載の油中水型エアゾール組成物の製法。8. The nonionic surfactant is blended with the oil component so that the total of the amount of the nonionic surfactant mixed with the water component is 0.05 to 10% by weight based on the stock solution. 7
A method for producing the water-in-oil type aerosol composition described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12173793A JP3161869B2 (en) | 1993-05-24 | 1993-05-24 | Water-in-oil aerosol composition and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12173793A JP3161869B2 (en) | 1993-05-24 | 1993-05-24 | Water-in-oil aerosol composition and process for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06329532A true JPH06329532A (en) | 1994-11-29 |
| JP3161869B2 JP3161869B2 (en) | 2001-04-25 |
Family
ID=14818638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12173793A Expired - Fee Related JP3161869B2 (en) | 1993-05-24 | 1993-05-24 | Water-in-oil aerosol composition and process for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3161869B2 (en) |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003035015A1 (en) * | 2001-10-26 | 2003-05-01 | Taiyo Kagaku Co., Ltd. | Composition for oily foamable aerosol |
| JP2003292431A (en) * | 2002-04-02 | 2003-10-15 | Pola Chem Ind Inc | Aerosol cosmetic containing bleaching agent |
| JP2004168715A (en) * | 2002-11-20 | 2004-06-17 | Pola Chem Ind Inc | Foamed external preparation for skin |
| JP2006265137A (en) * | 2005-03-23 | 2006-10-05 | Daizo:Kk | Emulsion type aerosol composition |
| JP2006321771A (en) * | 2005-05-20 | 2006-11-30 | Basf Japan Ltd | Aerosol composition for human body containing vitamins |
| WO2016056350A1 (en) * | 2014-10-10 | 2016-04-14 | 学校法人神奈川大学 | Emulsion composition for aerosol preparation, and aerosol agent |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
| US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
| US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
-
1993
- 1993-05-24 JP JP12173793A patent/JP3161869B2/en not_active Expired - Fee Related
Cited By (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9283162B2 (en) | 2001-10-26 | 2016-03-15 | Taiyo Kagaku Co., Ltd. | Composition for oily foamable aerosol |
| WO2003035015A1 (en) * | 2001-10-26 | 2003-05-01 | Taiyo Kagaku Co., Ltd. | Composition for oily foamable aerosol |
| JP2003292431A (en) * | 2002-04-02 | 2003-10-15 | Pola Chem Ind Inc | Aerosol cosmetic containing bleaching agent |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
| US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| JP2004168715A (en) * | 2002-11-20 | 2004-06-17 | Pola Chem Ind Inc | Foamed external preparation for skin |
| US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| JP2006265137A (en) * | 2005-03-23 | 2006-10-05 | Daizo:Kk | Emulsion type aerosol composition |
| JP2006321771A (en) * | 2005-05-20 | 2006-11-30 | Basf Japan Ltd | Aerosol composition for human body containing vitamins |
| US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
| US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
| US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
| US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US12138311B2 (en) | 2009-10-02 | 2024-11-12 | Journey Medical Corporation | Topical tetracycline compositions |
| US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
| US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US10946101B2 (en) | 2009-10-02 | 2021-03-16 | Vyne Therapeutics Inc. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| KR20170067843A (en) * | 2014-10-10 | 2017-06-16 | 각고우호우진 가나가와 다이가쿠 | Emulsion composition for aerosol preparation, and aerosol agent |
| JP2016079107A (en) * | 2014-10-10 | 2016-05-16 | 学校法人神奈川大学 | Emulsion composition for making aerosol and aerosol agent |
| WO2016056350A1 (en) * | 2014-10-10 | 2016-04-14 | 学校法人神奈川大学 | Emulsion composition for aerosol preparation, and aerosol agent |
| US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3161869B2 (en) | 2001-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH06329532A (en) | Water-in-oil aerosol composition and production process thereof | |
| JP3558393B2 (en) | Foamable aerosol composition | |
| DE19924277A1 (en) | Preparations of emulsion type W / O with increased water content containing medium polar lipids and silicone emulsifiers and optionally cationic polymers | |
| JP2009126791A (en) | Oil-in-poly emulsion emulsified cosmetics | |
| JP2002509556A (en) | Two-phase cosmetic composition | |
| KR20110102336A (en) | Personal hygiene compositions containing volatiles and terpene alcohol | |
| JPH06256133A (en) | Makeup stick | |
| KR100953144B1 (en) | Foam type massage mousse pack cosmetic composition using carbon dioxide as propellant | |
| AU2017263532A1 (en) | Whipped formulations | |
| JP6554394B2 (en) | Cosmetics | |
| JP2003026545A (en) | Hair cosmetic | |
| KR102909403B1 (en) | Oil-in-water cosmetic compositon | |
| JP3543523B2 (en) | Body cosmetics | |
| JP3975060B2 (en) | A liquid-liquid two-layer cosmetic comprising an aqueous layer and an oil layer | |
| KR100740598B1 (en) | Oil-in-water emulsion cosmetic composition | |
| JPS6231975B2 (en) | ||
| JP5552248B2 (en) | Water-in-oil emulsion composition | |
| KR100722677B1 (en) | High water-in-oil emulsified cosmetic composition | |
| JP3862076B2 (en) | Post-foaming pack fee | |
| JP3079178B2 (en) | Aerosol composition | |
| WO2004103324A1 (en) | Hair care emulsions | |
| JP2000119132A (en) | Aerosol composition | |
| JPH01294615A (en) | Two layer type cosmetic | |
| JP3492952B2 (en) | Liquid-liquid two-layer cosmetic consisting of water layer and oil layer | |
| JP2002161015A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130223 Year of fee payment: 12 |
|
| LAPS | Cancellation because of no payment of annual fees |